February 24, 2024

Consumer Genomics Market Size To Rake USD 17.51 Bn By 2032

The global consumer genomics market size was valued at USD 2.87 billion in 2022 and is projected to reach USD 17.51 billion by 2032, growing at a CAGR of 19.82% from 2023 to 2032, According to Precedence Research.

Consumer Genomics Market Size 2023 To 2032

The global consumer genomics market boons an in-depth synopsis of the competitive landscape of the market globally, thus helping establishments understand the primary threats and prospects that players/vendors in the market are dealt with. It also incorporates thorough business profiles of some of the prime vendors in the market.

Download The Sample Copy For Better Understanding@https://www.precedenceresearch.com/sample/3018

Consumer Genomics Market Report Scope 

Report Coverage Details
Market Size in 2023 USD 3.44 Billion
Market Size by 2032 USD 17.51 Billion
Growth Rate from 2023 to 2032 CAGR of 19.82%
Largest Market North America
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered By Applications
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Also read: Automotive Films Market Size To Rake USD 13.56 Bn By 2032

Benefits of this market

  • This study analyses the market size and share for consumer genomics along with the present trends in the industry and forecasts for the future, showing investment opportunities for the future.
  • In order to compare the financial capabilities of the consumer genomics market in the present, a quantitative analysis is done of the market from 2023 to 2032.
  • It is clear from this brilliant presentation of Porter’s Five Forces that buyers and suppliers have a lot of potential to gain from one another.
  • It is important to understand the most profitable trends in the consumer genomics market in order to gain an advantage in the market.
  • A comprehensive analysis of the driving factors, limitations, and opportunities is provided in the report, along with an in-depth analysis of the effect they have on the market.
  • The report also includes the market share for consumer genomics for several significant vendors as well as the latest developments in the market.

Leading players of the global consumer genomics market are analysed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. Precedence Research provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global consumer genomics market. Furthermore, the report offers two separate market forecasts – one for the production side and another for the consumption side of the global consumer genomics market. It also provides useful recommendations for new as well as established players of the global consumer genomics market.

The major players in the market

  • Ancestry
  • Gene By Gene, Ltd. (FamilyTree DNA)
  • 23andMe, Inc.
  • Color Genomics, Inc.
  • Myriad Genetics, Inc.
  • Mapmygenome
  • Positive Biosciences, Ltd.
  • Futura Genetics
  • Helix OpCo LLC
  • MyHeritage Ltd.
  • Pathway Genomics
  • Amgen, Inc.
  • Xcode Life
  • Diagnomics, Inc.
  • Toolbox Genomics
  • SomaLogic, Inc.
  • Inui Health (formerly Scanadu)
  • AgeCurve
  • QuickCheck Health
  • Biomeb

Consumer Genomics Market Segmentations:

By Applications

  • Genetic Relatedness
  • Diagnostics
  • Lifestyle, Wellness, & Nutrition
  • Ancestry
  • Reproductive Health
  • Personalized Medicine & Pharmacogenetic testing
  • Sports Nutrition & Health
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Consumer Genomics Market

5.1. COVID-19 Landscape: Consumer Genomics Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Consumer Genomics Market, By Applications

8.1. Consumer Genomics Market, by Applications Type, 2023-2032

8.1.1. Genetic Relatedness

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Diagnostics

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Lifestyle, Wellness, & Nutrition

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Ancestry

8.1.4.1. Market Revenue and Forecast (2020-2032)

8.1.5. Reproductive Health

8.1.5.1. Market Revenue and Forecast (2020-2032)

8.1.6. Personalized Medicine & Pharmacogenetic testing

8.1.6.1. Market Revenue and Forecast (2020-2032)

8.1.7. Sports Nutrition & Health

8.1.7.1. Market Revenue and Forecast (2020-2032)

8.1.8. Others

8.1.8.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Consumer Genomics Market, Regional Estimates and Trend Forecast

9.1. North America

9.1.1. Market Revenue and Forecast, by Applications (2020-2032)

9.1.2. U.S.

9.1.2.1. Market Revenue and Forecast, by Applications (2020-2032)

9.1.3. Rest of North America

9.1.3.1. Market Revenue and Forecast, by Applications (2020-2032)

9.2. Europe

9.2.1. Market Revenue and Forecast, by Applications (2020-2032)

9.2.2. UK

9.2.2.1. Market Revenue and Forecast, by Applications (2020-2032)

9.2.3. Germany

9.2.3.1. Market Revenue and Forecast, by Applications (2020-2032)

9.2.4. France

9.2.4.1. Market Revenue and Forecast, by Applications (2020-2032)

9.2.5. Rest of Europe

9.2.5.1. Market Revenue and Forecast, by Applications (2020-2032)

9.3. APAC

9.3.1. Market Revenue and Forecast, by Applications (2020-2032)

9.3.2. India

9.3.2.1. Market Revenue and Forecast, by Applications (2020-2032)

9.3.3. China

9.3.3.1. Market Revenue and Forecast, by Applications (2020-2032)

9.3.4. Japan

9.3.4.1. Market Revenue and Forecast, by Applications (2020-2032)

9.3.5. Rest of APAC

9.3.5.1. Market Revenue and Forecast, by Applications (2020-2032)

9.4. MEA

9.4.1. Market Revenue and Forecast, by Applications (2020-2032)

9.4.2. GCC

9.4.2.1. Market Revenue and Forecast, by Applications (2020-2032)

9.4.3. North Africa

9.4.3.1. Market Revenue and Forecast, by Applications (2020-2032)

9.4.4. South Africa

9.4.4.1. Market Revenue and Forecast, by Applications (2020-2032)

9.4.5. Rest of MEA

9.4.5.1. Market Revenue and Forecast, by Applications (2020-2032)

9.5. Latin America

9.5.1. Market Revenue and Forecast, by Applications (2020-2032)

9.5.2. Brazil

9.5.2.1. Market Revenue and Forecast, by Applications (2020-2032)

9.5.3. Rest of LATAM

9.5.3.1. Market Revenue and Forecast, by Applications (2020-2032)

Chapter 10. Company Profiles

10.1. Ancestry

10.1.1. Company Overview

10.1.2. Product Offerings

10.1.3. Financial Performance

10.1.4. Recent Initiatives

10.2. Gene By Gene, Ltd. (FamilyTree DNA)

10.2.1. Company Overview

10.2.2. Product Offerings

10.2.3. Financial Performance

10.2.4. Recent Initiatives

10.3. 23andMe, Inc.

10.3.1. Company Overview

10.3.2. Product Offerings

10.3.3. Financial Performance

10.3.4. Recent Initiatives

10.4. Color Genomics, Inc.

10.4.1. Company Overview

10.4.2. Product Offerings

10.4.3. Financial Performance

10.4.4. Recent Initiatives

10.5. Myriad Genetics, Inc.

10.5.1. Company Overview

10.5.2. Product Offerings

10.5.3. Financial Performance

10.5.4. Recent Initiatives

10.6. Mapmygenome

10.6.1. Company Overview

10.6.2. Product Offerings

10.6.3. Financial Performance

10.6.4. Recent Initiatives

10.7. Positive Biosciences, Ltd.

10.7.1. Company Overview

10.7.2. Product Offerings

10.7.3. Financial Performance

10.7.4. Recent Initiatives

10.8. Futura Genetics

10.8.1. Company Overview

10.8.2. Product Offerings

10.8.3. Financial Performance

10.8.4. Recent Initiatives

10.9. Helix OpCo LLC

10.9.1. Company Overview

10.9.2. Product Offerings

10.9.3. Financial Performance

10.9.4. Recent Initiatives

10.10. MyHeritage Ltd.

10.10.1. Company Overview

10.10.2. Product Offerings

10.10.3. Financial Performance

10.10.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research

11.2. Secondary Research

11.3. Assumptions

Chapter 12. Appendix

12.1. About Us

12.2. Glossary of Terms

Key inquiries addressed in the report:

  • Investigate the COVID 19 outbreak’s effects.
  • Our researchers give precise responses, pinpoint significant chances and fresh investments, and suggest excellent market strategy avenues.

Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com

Leave a Reply

Your email address will not be published. Required fields are marked *